Cargando…

In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment

The worse outcome of COVID-19 in people with diabetes mellitus could be related to the non-enzymatic glycation of human ACE2, leading to a more susceptible interaction with virus Spike protein. We aimed to evaluate, through a computational approach, the interaction between human ACE2 receptor and SA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sartore, Giovanni, Bassani, Davide, Ragazzi, Eugenio, Traldi, Pietro, Lapolla, Annunziata, Moro, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613179/ https://www.ncbi.nlm.nih.gov/pubmed/34819560 http://dx.doi.org/10.1038/s41598-021-02297-w

Ejemplares similares

Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus
por: Bassani, Davide, et al.
Publicado: (2022)

A role of glycation and methylation for SARS-CoV-2 infection in diabetes?
por: Sartore, Giovanni, et al.
Publicado: (2020)

Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update
por: Sartore, Giovanni, et al.
Publicado: (2023)

Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A cross-sectional observational study
por: Sartore, Giovanni, et al.
Publicado: (2023)

Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial
por: Sartore, Giovanni, et al.
Publicado: (2021)

Mediterranean Diet and Red Yeast Rice Supplementation for the Management of Hyperlipidemia in Statin-Intolerant Patients with or without Type 2 Diabetes
por: Giovanni, Sartore, et al.
Publicado: (2013)

Erratum to “Mediterranean Diet and Red Yeast Rice Supplementation for the Management of Hyperlipidemia in Statin-Intolerant Patients with or without Type 2 Diabetes”
por: Sartore, Giovanni, et al.
Publicado: (2014)

Proteomic Approaches in the Study of Placenta of Pregnancy Complicated by Gestational Diabetes Mellitus
por: Lapolla, Annunziata, et al.
Publicado: (2022)

Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects
por: Piarulli, Francesco, et al.
Publicado: (2017)

The Burden of Impaired Serum Albumin Antioxidant Properties and Glyco-Oxidation in Coronary Heart Disease Patients with and without Type 2 Diabetes Mellitus
por: Piarulli, Francesco, et al.
Publicado: (2022)

Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update
por: Piarulli, Francesco, et al.
Publicado: (2012)

Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study
por: Ragazzi, Eugenio, et al.
Publicado: (2023)

Mass Spectrometry for Diabetic Nephropathy Monitoring: New Effective Tools for Physicians
por: Lapolla, Annunziata, et al.
Publicado: (2012)

Protein Glycation in Diabetes as Determined by Mass Spectrometry
por: Lapolla, Annunziata, et al.
Publicado: (2013)

Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM
por: Sartore, Giovanni, et al.
Publicado: (2020)

Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes
por: Chilelli, Nino Cristiano, et al.
Publicado: (2016)

From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
por: Pavan, Matteo, et al.
Publicado: (2022)

ELISA based on peptide antigens reproducing cross-reactive viral epitopes to detect antibodies in latent autoimmune diabetes in adults vs. type 1 diabetes
por: Real-Fernández, Feliciana, et al.
Publicado: (2021)

Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2020)

SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species
por: Rendon-Marin, Santiago, et al.
Publicado: (2021)

In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2
por: Medina-Barandica, Jeffry, et al.
Publicado: (2023)

Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2021)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
por: Pavan, Matteo, et al.
Publicado: (2021)

In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor
por: Zhang, Yuzhao, et al.
Publicado: (2021)

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2021)

In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M(pro)
por: Bassani, Davide, et al.
Publicado: (2022)

Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
por: Yu, Ran, et al.
Publicado: (2022)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
por: Pavan, Matteo, et al.
Publicado: (2022)

In Silico, In Vitro and In Cellulo Models for Monitoring SARS-CoV-2 Spike/Human ACE2 Complex, Viral Entry and Cell Fusion
por: Lapaillerie, Delphine, et al.
Publicado: (2021)

Evaluation of Inhibitory Activity In Silico of In-House Thiomorpholine Compounds between the ACE2 Receptor and S1 Subunit of SARS-CoV-2 Spike
por: Vázquez-Valadez, Victor H., et al.
Publicado: (2021)

Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism?
por: Bolcato, Giovanni, et al.
Publicado: (2022)

Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M(pro) by Using Supervised Molecular Dynamics (SuMD) Simulations
por: Bissaro, Maicol, et al.
Publicado: (2021)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis
por: Kemenesi, Gábor, et al.
Publicado: (2021)

Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Piplani, Sakshi, et al.
Publicado: (2021)

Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike
por: Banerjee, Amrita, et al.
Publicado: (2022)

In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
por: Çubuk, Hasan, et al.
Publicado: (2022)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0b779le7pu1jmls9j3640rtpg6